SUBSPECIALTY CERTIFICATION IN DERMATOPATHOLOGY

Subspecialty certification in Dermatopathology is a joint and equal function of the American Board of Dermatology (ABD) and the American Board of Pathology (ABP). Such function will relate to qualifications of candidates, standards of examination, and the form of the certificate. Beginning in 2006, Dermatopathology certificates will have a 10-year time limit.

All candidates applying to sit for this certifying examination must hold a currently valid, full and unrestricted license to practice medicine or osteopathy in the state or province of his/her residence in either the United States or Canada. The candidate may be denied certification if his/her license has been revoked, suspended, restricted, or surrendered in any jurisdiction - or if the candidate is subject to adverse licensure proceedings.

All candidates for this certification must satisfy the following requirements:

  • Prerequisites
    • Primary certification by both the American Board of Dermatology and the American Board of Pathology (anatomic pathology or anatomic and clinical pathology) or
    • Primary certification by either the American Board of Dermatology or the American Board of Pathology (anatomic pathology or anatomic and clinical pathology), and the satisfactory completion of one year of training in dermatopathology in a program accredited for such training (see below) by the Accreditation Council for Graduate Medical Education (ACGME). The dermatologist applicant must spend one-half of the required training time in pathology. The pathologist applicant must spend one-half of the required training time in clinical dermatology.

  • Training
    Accredited institutional training programs in dermatopathology are an equal and joint function of the Departments of Dermatology and Pathology of that institution. Training programs in dermatopathology are reviewed and accredited by the Residency Review Subcommittee for Dermatopathology, which includes three members from the Residency Review Committee for Dermatology and three members from the Residency Review Committee for Pathology. Upon recommendation by this subcommittee, training programs in dermatopathology are accredited by conjoint action of the Residency Review Committees for Dermatology and Pathology acting with authority delegated by the Accreditation Council for Graduate Medical Education (ACGME). Information concerning accredited dermatopathology training programs may be found in the AMA Graduate Medical Education Directory or at www.acgme.org. It is the responsibility of directors of fellowships in Dermatopathology to make certain that their trainees file a preliminary registration form in the Board office by August 1st or within 30 days of the start of training.

  • Leave of Absence Policy for American Board of Dermatology Subspecialty Fellowship Training
    1. In general, high priority should be given to completing 12 continuous months of full time training.
    2. Any departure from (1), for example time lost for a medical leave of absence, should be documented and fully justified in the trainee evaluation forms filed by the training program director with the Board.
    3. It is necessary that 11 months of training are completed in order to qualify for subspecialty certification. Thus, without exception, any absence (inclusive of vacation) resulting in less than 11 months of training during a 12-month program will require an additional period of training to achieve 11 total months. Only when this requirement is documented by the program director will the trainee be qualified to take the subspecialty certifying examination. If the program director anticipates that this additional training will be completed in a satisfactory manner before September 1, the Board may allow the trainee to take the certifying examination in that year.
  • Examination - Deadline for Application and Date of Examination
    Candidates who have satisfied the above requirements are eligible to apply to the Board to take the examination for subspecialty certification in Dermatopathology, which is a comprehensive assessment of the candidates' knowledge of dermatopathology, including the related basic sciences, and laboratory and clinical areas pertaining to this discipline.

    Dermatologist candidates planning to take the subspecialty certification examination should request an application from the office of the Executive Director of the American Board of Dermatology. Applications can also be downloaded (click on "Candidate Application" above). The deadline for receipt of applications is May 1st of the year in which the candidate plans to take the examination. The next examination will be given on Monday, September 15, 2008 in Tampa, Florida. The deadline for receipt of applications is May 1, 2008. The fee for the 2008 examination is $1,800. The fee may be sent in the form of a check or credit card number (the Board accepts American Express, MasterCard and VISA).

  • Appeals Process
    An appeals procedure similar to that described for the certification process in dermatology is available for candidates for subspecialty certification in Dermatopathology who were declared ineligible by the Board for Dermatopathology or who failed the Dermatopathology examination. Candidates submitting such appeals should contact the Board for current additional information.
  • Maintenance of Certification
    Certification in Dermatopathology is time-limited for 10 years. When a candidate is certified in Dermatopathology, he/she will enter into Maintenance of Certification for the 10-year period. See the Maintenance of Certification requirements

 

 

JOINT POLICY COMMITTEE FOR DERMATOPATHOLOGY

John V. Collin, M.D.*, Chair (ABP)
Terry L. Barrett, M.D. Vice Chair(ABD)
Thomas D. Horn, M.D. (ABD)
James W. Patterson, M.D. (ABD)
Robert McKenna, M.D.*,(ABP)
Sharon A. Weiss, M.D.* (ABP)
Betsy D. Bennett, M.D.* (Staff, ABP)
Antoinette F. Hood, M.D. (Staff, ABD)
DERMATOPATHOLOGY TEST DEVELOPMENT AND ADVISORY COMMITTEE

Terry L. Barrett, M.D., Co-Chair (ABD)
Sharon A. Weiss, M.D., Co-Chair (ABP)
Steven D. Billings, M.D.* (ABP)
John A. Carlson, M.D.*, (ABP)
Marsha L. Chaffins, M.D.* (ABD)
Dirk M. Elston, M.D.* (ABD)
Joan Guitart, M.D.* (ABD)
Jeff D. Harvell, M.D.* (ABP)
Beth S. Ruben, M.D.* (ABD)
Oscar P. Sangueza, M.D.* (ABP)
Betsy D. Bennett, M.D.* (Staff, ABP)
Antoinette F. Hood, M.D. (Staff, ABD)

*Non-ABD or non-ABP Director members of the Test Committee.